Connect with us

National

Vaccine can be quickly adapted to counter new strain: BioNTech

Published

on

views
Vaccine can be quickly adapted to counter new strain: BioNTech thumbnail
Spread the love

January 10, 2021 5:00 AM

The Covid-19 vaccine developed by Pfizer and BioNTech – and currently used in Singapore – can be quickly modified if the virus mutates to the extent that the vaccine is no longer effective against it, said BioNTech’s chief strategy officer and managing director Ryan Richardson.
Read More >>